[e-farmacos] WHO Drug Information vol 20, num 2

["Madurga, Mariano" <mmadurga@agemed.es>]

Estimadas y estimados,

Acaba de salir el n 2, vol 20 de la revista WHO Drug Information, con el siguiente indice:

----------------------------------------- 
WHO DRUG INFORMATION, VOLUME 20 NUMBER 2 
TABLE OF CONTENTS  
----------------------------------------- 
Regulatory Issues 
Drug Regulation in 2006: vision and challenges  61 
International Conference of Drug Regulatory Authorities (ICDRA): recommendations        61 

Safety and Efficacy Issues 
Tenofovir and nonsteroidal anti-inflammatories: acute renal failure     69 
Update on status of contraceptive skin patch    69 
SSRI antidepressants linked to lung disorder in newborns        70 
ACE inhibitors and birth defects        70 
ACE inhibitors and pregnancy    71 
Gadolinium-containing contrast agents and nephrogenic systemic fibrosis 71 
Gatifloxacin and blood glucose disturbances     72 

Essential Medicines 
WHO Model List of Essential Medicines and developed countries: a comparison     with the Lothian Joint Formulary        73

Adherence to WHO's Model List of Essential Medicines in two European countries  78 

Regulatory Action and News 
Transgenic antithrombin alfa approved   86 
EMEA Management Board moves for greater transparency    86 
Bupropion approved for seasonal depression      86 
Decitabine approved for myelodysplastic syndromes               87 
Medical device innovation initiative            88 
Topotecan/cisplatin for late-stage cervical cancer      88 
Rapid approval of vaccine for prevention of cervical cancer     89 
Rasagiline approved for Parkinson disease       89 
Fluoxetine approved for children and adolescents        89 
Withdrawal of marketing application for Surfaxin®       89 
Resumed marketing of natalizumab        90 
EU Regulation on compulsory licensing   published       90 

Emerging Diseases 
Tissue infectivity and transmissible spongiform encephalopathies        91 

ATC/DDD Classification 
ATC/DDD Classification (temporary)      97 
ATC/DDD Classification (final)  100 

Recent Publications, Information and Events 
Interagency Emergency Health Kit 2006   103 
Therapeutic guidelines for rheumatology 103 
Specifications for pharmaceutical preparations  103 
New guidance for pharmacists on counterfeit medicines   104 
Marketed unapproved drugs - policy guide        104 
WHO guidelines on avian influenza       104 
WHO analgesic ladder    105 
Resources for paediatric formulations   104 

Consultation Document 
International Pharmacopoeia: revision of monographs for antimalarials and draft proposals for antiretrovirals 
        Artesunate      106 
        Artesunate tablets      107 
        Lamivudine oral solution        107 
        Lamivudine tablets      109 
        Zidovudine and lamivudine tablets       112 

Proposed International Nonproprietary Names: List 95 


Esta disponible en internet en:
http://www.who.int/druginformation  

Un abrazo,

Mariano Madurga Sanz
Jefe de Servicio de Coordinacion del SEFV
División de Farmacoepidemiología y Farmacovigilancia
Agencia Espanhola de Medicamentos y Productos Sanitarios
28022-Madrid
(Espanha)

Correo-e: mmadurga@agemed.es 
Internet: www.agemed.es